Clinical trial
Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate…
NCT00003307 · University of Arizona, Other · Completed
Key facts
| NCT number | NCT00003307 |
|---|---|
| Title | Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer |
| Official title | A Phase II Open Label Trial of Amifostine Plus Fractionated Radiotherapy for Primary Prostate Adenocarcinoma (T1a-T3b, NoMo, PSA>10 ng/ml) to Estimate Acute Grade 2 Genitourinary and Gastrointestinal Toxicity |
| Lead sponsor | University of Arizona, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer, Radiation Toxicity |
| Intervention type | Drug, Radiation |
| Interventions | amifostine trihydrate, radiation therapy |
| Enrollment | 25 |
| Start date | Mar 1, 1998 |
| Primary completion | Jun 1, 2001 |
| Completion | Jun 1, 2001 |
| First posted | Apr 14, 2004 |
| Last update posted | Mar 16, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: